Furthermore, the expression of OGR1 correlates with higher clinical scores in IBD patients, suggesting that OGR1 has a clinically relevant pro-inflammatory effect that could be targeted for treatment [22, 25]. This evidence concerns the gene GPR68 and inflammatory bowel disease.